Y-Biologics have open business model based on two platform technologies (Ymax-ABL, ALiCE) & Pipelines.
We are amenable to various partnerships, including out-licensing, research collaborations and co-development, especially
those companies with experience and expertise in the clinical development of bi-specific antibodies.
Platform Technology & Pipeline
- Novel BsAb Platform
- Antibody Pipeline in
- Human Antibody
- Research Collaboration
- Contact us
Use the contact form
below send us a message. * indicates required field